Skip to content
Inciteful Med
Resources About us Ask a Question

What Are the Best EDS Pain Management Strategies?

Published: | Updated:

Effective Ehlers-Danlos Syndrome (EDS) pain management requires a multimodal approach because the pain often stems from joint instability and central sensitization. The best strategies combine specialized physical therapy, custom bracing, pacing, and targeted nerve pain medications.

Key Takeaways

  • • EDS pain is complex and often driven by central sensitization, making standard over-the-counter painkillers less effective.
  • • Specialized physical therapy programs are crucial for safely building muscle strength to support hypermobile joints without causing injury.
  • • Custom bracing, silver ring splints, and mobility aids provide essential mechanical support to prevent painful joint subluxations.
  • • Doctors may prescribe off-label medications like Low-Dose Naltrexone (LDN) or neuropathic pain drugs to calm an overactive nervous system.
  • • Muscle relaxers are typically best used at bedtime to prevent compromising the daytime muscle tone needed to stabilize hypermobile joints.

When over-the-counter painkillers like ibuprofen or acetaminophen fail to relieve joint and muscle pain, it can feel incredibly discouraging. For people with Ehlers-Danlos Syndrome (EDS), standard pain medications often fall short because EDS pain is complex. It stems not just from joint instability and micro-injuries, but frequently from central sensitization—a condition where the nervous system becomes hyper-reactive and amplifies pain signals [1][2]. Because of this, effectively managing chronic EDS pain requires a long-term, “multimodal” approach. This means combining specific non-pharmacological therapies, specialized medications, and supportive tools tailored to your unique body, rather than relying on a single pill [3][4][5].

The Foundation: Specialized Physical Therapy & Pacing

Physical therapy is a cornerstone of EDS pain management, but standard PT can sometimes cause symptom flare-ups or iatrogenic (treatment-caused) injuries [6][7][8]. Traditional stretching and heavy weightlifting can put too much stress on fragile, hypermobile joints.

  • Progressive Strengthening: Specialized protocols, such as the Muldowney Protocol, focus on progressive, foundational muscle strengthening [9][6][7]. The goal is to build strong, stable muscles around the joints to compensate for lax connective tissues. These specialized programs typically begin with low-load, isometric exercises—where muscles contract without the joint moving—and slowly advance to more dynamic movements as stability improves [6][7][8]. Many patients find individualized, joint-protective rehabilitation essential for long-term relief [10][5][4].
  • Pacing and Energy Conservation: Because EDS pain is frequently intertwined with chronic fatigue, managing your “energy envelope” is crucial. Learning to pace your activities to avoid the “boom and bust” cycle of overexertion on good days helps prevent severe pain flares.

Pain Psychology for Central Sensitization

Because central sensitization is a primary driver of EDS pain, psychological and somatic therapies are evidence-based, first-line tools [1][3]. Practices like Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), and pain reprocessing therapy can help down-regulate an over-reactive nervous system, altering how the brain interprets pain signals.

Mechanical Support: Bracing and Modalities

To manage daily pain and prevent subluxations (partial dislocations), mechanical supports and physical modalities can offer significant relief:

  • Custom Bracing and Silver Ring Splints: Occupational therapy often utilizes custom orthotics or silver ring splints for the hands to prevent fingers from bending backward, stabilizing joints while allowing functional movement [11][12][8]. Specialized compression garments can also help improve shoulder and core stability [13][14].
  • Mobility Aids: Canes, rollators, and wheelchairs are valid, empowering pain management tools. Using them for pacing can prevent severe pain flares and help maintain independence.
  • TENS Units and Thermal Therapy: Transcutaneous Electrical Nerve Stimulation (TENS) units, heating pads, or ice packs remain accessible options for managing localized pain [11][12]. Caution: If you have Classical (cEDS) or Dermatosparaxis (dEDS) subtypes, be extremely careful with TENS adhesives, which can cause severe skin tearing or blistering.

Pharmacological Approaches

Because EDS pain mimics neuropathic (nerve-related) pain, doctors frequently prescribe medications “off-label” to target the nervous system directly [2][1]:

  • Neuropathic Pain Medications: Medications typically used for nerve pain or fibromyalgia, such as gabapentinoids or tricyclic antidepressants, are often prescribed to calm an overactive nervous system [2][1].
  • Low-Dose Naltrexone (LDN): LDN is increasingly used off-label to manage complex chronic pain. It is believed to act as an anti-inflammatory by blocking certain immune receptors and modulating the body’s natural pain-relieving opioid systems [15][16][17]. LDN has shown a favorable safety profile and symptom improvement for overlapping conditions like fibromyalgia and chronic fatigue [18][19][20]. The effective dose is highly individualized, often starting very low and titrating up [21][22][23].
  • Muscle Relaxers: Because muscles often spasm to “guard” and stabilize hypermobile joints, overly relaxing them during the day can worsen joint instability [24]. A common strategy is taking muscle relaxers strictly at bedtime to relieve spasms and improve sleep, while avoiding them during the day when muscle tone is needed to stay safely upright.
  • Traditional Analgesics: While standard NSAIDs are often poorly effective for central sensitization, they can be useful for acute inflammatory flares immediately after a subluxation or micro-tear. Opioids may occasionally be used for acute pain crises, but long-term use is usually avoided due to safety concerns and connective tissue laxity risks [25][26][27].
  • Caution with Localized Steroids: Routine localized corticosteroid injections for joint pain should be approached with caution, as repeated use can further weaken fragile connective tissues and increase tendon rupture risks.
  • Emerging Therapies: Many patients research regenerative medicine (like Prolotherapy or PRP) or medical cannabis. While popular, there is currently a lack of large-scale clinical trials proving their safety and efficacy specifically in EDS populations [24].

A Note on EDS Subtypes

Pain management must be tailored to your specific EDS subtype, as interventions carry differing risks:

  • Hypermobile EDS (hEDS): Focuses on multidisciplinary strategies, targeting joint instability, central sensitization, and comorbidities like POTS [28][1][3].
  • Classical (cEDS) and Classical-like (clEDS): Physical therapy protocols overlap with hEDS, but providers must be vigilant for skin tearing (especially with medical adhesives) and potential vascular complications [29][30][31]. Vascular fragility is a recognized risk [32][33][34].
  • Vascular EDS (vEDS): Management requires extreme caution. Due to the high risk of catastrophic events like spontaneous arterial or organ rupture, physical interventions and surgical procedures must be carefully evaluated [35][36][37]. Minimally invasive, conservative approaches are prioritized [38][39][40].
  • Spondylodysplastic (spEDS) and Dermatosparaxis (dEDS): These require approaches accounting for severe skin fragility (dEDS) or skeletal abnormalities (spEDS), emphasizing gentle, non-traumatic joint support.

Navigating Care and Building a Team

The most effective approach is often found in interdisciplinary pain management clinics that understand hypermobility [41][42][43]. These programs coordinate physical therapy, occupational therapy, and psychosocial support to address your entire well-being [1][44][3].

However, EDS-literate clinics are incredibly rare, frequently have long waitlists, or may not accept insurance [45][46][47]. If a specialized clinic isn’t accessible, you can try building your own “piecemeal” care team. Look for an open-minded Primary Care Provider (PCP) to coordinate medications, a physical therapist willing to learn hypermobility protocols, and an occupational therapist for custom splinting. Bringing evidence-based resources to these appointments can help educate providers and foster a collaborative approach.

Frequently Asked Questions

Why do standard pain medications often fail for EDS?
Standard medications like ibuprofen often fail because EDS pain is complex and frequently involves central sensitization. This means the nervous system becomes hyper-reactive and amplifies pain signals, requiring targeted therapies rather than just standard anti-inflammatory pills.
Is traditional physical therapy safe for Ehlers-Danlos Syndrome?
Standard physical therapy involving heavy lifting or traditional stretching can sometimes cause flare-ups or injuries in people with EDS. Instead, specialized programs focus on progressive, low-load exercises to build stabilizing muscles safely around fragile joints.
How can Low-Dose Naltrexone (LDN) help with EDS pain?
LDN is increasingly prescribed to manage complex chronic pain in EDS by acting as an anti-inflammatory and modulating the body's natural pain-relieving systems. It is typically started at a very low dose and adjusted gradually by your doctor.
Should I take muscle relaxers during the day for EDS spasms?
Taking muscle relaxers during the day can worsen joint instability because your muscles are often spasming to 'brace' and stabilize hypermobile joints. Doctors typically recommend taking them strictly at bedtime to improve sleep while maintaining necessary muscle tone during the day.
What are silver ring splints used for?
Silver ring splints are custom orthotics used to prevent fingers from bending backward. They stabilize hypermobile hand joints while still allowing you to maintain functional daily movement.

Questions for Your Doctor

  • • Given that my pain seems to involve central sensitization, would a trial of Low-Dose Naltrexone (LDN) or a neuropathic pain medication be appropriate for my pain profile?
  • • Can you refer me to a physical therapist who has experience with hypermobility protocols, or an occupational therapist to fit me for custom ring splints?
  • • How can we safely use muscle relaxers to help me sleep without worsening my daytime joint instability?
  • • Are there local pain psychology resources or pacing programs that can help me manage the nervous system component of my pain?

Questions for You

  • • Do I notice my pain worsening after standard stretching or traditional physical therapy exercises?
  • • Are my muscle spasms acting as a necessary 'brace' to hold my unstable joints together during the day?
  • • Do I experience signs of central sensitization, such as widespread pain that feels amplified, or sensitivity to light touch and temperature?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Pain in hypermobile Ehlers-Danlos syndrome: New insights using new criteria.

    Bénistan K, Martinez V

    American journal of medical genetics. Part A 2019; (179(7)):1226-1234 doi:10.1002/ajmg.a.61175.

    PMID: 31075184
  2. 2

    Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.

    Di Stefano G, Celletti C, Baron R, et al.

    European journal of pain (London, England) 2016; (20(8)):1319-25 doi:10.1002/ejp.856.

    PMID: 26919608
  3. 3

    Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.

    Chuchin JD, Ornstein TJ

    Disability and rehabilitation 2024; (46(18)):4234-4245 doi:10.1080/09638288.2023.2268520.

    PMID: 37843031
  4. 4

    The GoodHope Ehlers Danlos Syndrome Clinic: development and implementation of the first interdisciplinary program for multi-system issues in connective tissue disorders at the Toronto General Hospital.

    Mittal N, Mina DS, McGillis L, et al.

    Orphanet journal of rare diseases 2021; (16(1)):357 doi:10.1186/s13023-021-01962-7.

    PMID: 34376220
  5. 5

    Psychiatric and psychological aspects in the Ehlers-Danlos syndromes.

    Bulbena A, Baeza-Velasco C, Bulbena-Cabré A, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2017; (175(1)):237-245 doi:10.1002/ajmg.c.31544.

    PMID: 28186381
  6. 6

    Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.

    Garreth Brittain M, Flanagan S, Foreman L, Teran-Wodzinski P

    Disability and rehabilitation 2024; (46(10)):1936-1953 doi:10.1080/09638288.2023.2216028.

    PMID: 37231592
  7. 7

    Orthopaedic Manifestations in Hypermobile Ehlers-Danlos Syndrome.

    Eichinger JK, Byrd RL, Bailey EP, et al.

    The Journal of bone and joint surgery. American volume 2025; (107(16)):1848-1856 doi:10.2106/JBJS.24.01106.

    PMID: 40638721
  8. 8

    Quality of life, unmet needs, and iatrogenic injuries in rehabilitation of patients with Ehlers-Danlos Syndrome hypermobility type/Joint Hypermobility Syndrome.

    Bovet C, Carlson M, Taylor M

    American journal of medical genetics. Part A 2016; (170(8)):2044-51 doi:10.1002/ajmg.a.37774.

    PMID: 27273746
  9. 9

    Recognizing and Effectively Managing Hypermobility-Related Conditions.

    Russek LN, Stott P, Simmonds J

    Physical therapy 2019; (99(9)):1189-1200 doi:10.1093/ptj/pzz078.

    PMID: 31158283
  10. 10

    A Comprehensive Review: Chronic Pain Sequelae in the Presence of Ehlers-Danlos Syndrome.

    Basem JI, Lin T, Mehta ND

    Current pain and headache reports 2022; (26(12)):871-876 doi:10.1007/s11916-022-01093-z.

    PMID: 36434419
  11. 11

    Physical and mechanical therapies for lower limb symptoms in children with Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: a systematic review.

    Peterson B, Coda A, Pacey V, Hawke F

    Journal of foot and ankle research 2018; (11()):59 doi:10.1186/s13047-018-0302-1.

    PMID: 30455744
  12. 12

    Hypermobile Ehlers-Danlos syndrome and rehabilitation: taking stock of evidence based medicine: a systematic review of the literature.

    Corrado B, Ciardi G

    Journal of physical therapy science 2018; (30(6)):843-847 doi:10.1589/jpts.30.847.

    PMID: 29950777
  13. 13

    VETCOSED study: efficacy of compressive garments for patients with hypermobile Ehlers-Danlos syndrome on shoulder stability and muscles strength.

    Chaléat-Valayer E, Denis A, Zelmar A, et al.

    Disability and rehabilitation 2022; (44(13)):3165-3172 doi:10.1080/09638288.2020.1860142.

    PMID: 33353449
  14. 14

    Management of shoulder instability in hypermobility-type Ehlers-Danlos syndrome.

    Broida SE, Sweeney AP, Gottschalk MB, Wagner ER

    JSES reviews, reports, and techniques 2021; (1(3)):155-164 doi:10.1016/j.xrrt.2021.03.002.

    PMID: 37588970
  15. 15

    Naltrexone a potential therapeutic candidate for COVID-19.

    Choubey A, Dehury B, Kumar S, et al.

    Journal of biomolecular structure & dynamics 2022; (40(3)):963-970 doi:10.1080/07391102.2020.1820379.

    PMID: 32930058
  16. 16

    Successful treatment of dermatomyositis with low-dose naltrexone.

    Tran T, Chen A, Worswick S

    Dermatologic therapy 2018; (31(6)):e12720 doi:10.1111/dth.12720.

    PMID: 30246915
  17. 17

    Low-Dose Naltrexone reduces symptoms in Stiff-Person Syndrome.

    Zappaterra M, Shouse E, Levine RL

    Medical hypotheses 2020; (137()):109546 doi:10.1016/j.mehy.2019.109546.

    PMID: 31954293
  18. 18

    Low Dose Naltrexone In The Management Of Chronic Pain Syndrome: A Meta-Analysis Of Randomized Controlled Clinical Trials.

    Hegde NC, Mishra A, V D, et al.

    Current pain and headache reports 2025; (29(1)):96 doi:10.1007/s11916-025-01411-1.

    PMID: 40540205
  19. 19

    The Use of Low-Dose Naltrexone for Chronic Pain.

    Bostick KM, McCarter AG, Nykamp D

    The Senior care pharmacist 2019; (34(1)):43-46 doi:10.4140/TCP.n.2019.43.

    PMID: 30821677
  20. 20

    Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome: A Case Series.

    Stallkamp Tidd SJ, Cantrell C, Greene BD, Wilson R

    Cureus 2023; (15(8)):e43426 doi:10.7759/cureus.43426.

    PMID: 37706146
  21. 21

    Effective Doses of Low-Dose Naltrexone for Chronic Pain - An Observational Study.

    Marcus NJ, Robbins L, Araki A, et al.

    Journal of pain research 2024; (17()):1273-1284 doi:10.2147/JPR.S451183.

    PMID: 38532991
  22. 22

    Low-Dose Naltrexone for the Treatment of Fibromyalgia: Investigation of Dose-Response Relationships.

    Bruun-Plesner K, Blichfeldt-Eckhardt MR, Vaegter HB, et al.

    Pain medicine (Malden, Mass.) 2020; (21(10)):2253-2261 doi:10.1093/pm/pnaa001.

    PMID: 32068870
  23. 23

    Low Dose Naltrexone in Conjunction With the Wahls Protocol to Reduce the Frequency of Chronic Migraines in a Patient With Multiple Sclerosis: A Case Study.

    Codino H, Hardin A

    Integrative medicine (Encinitas, Calif.) 2021; (20(3)):30-34.

    PMID: 34377098
  24. 24

    Multidisciplinary Approach to Treating Chronic Pain in Patients with Ehlers-Danlos Syndrome: Critically Appraised Topic.

    Whalen KC, Crone W

    Journal of pain research 2022; (15()):2893-2904 doi:10.2147/JPR.S377790.

    PMID: 36124037
  25. 25

    Pain control methods in use and perceived effectiveness by patients with Ehlers-Danlos syndrome: a descriptive study.

    Arthur K, Caldwell K, Forehand S, Davis K

    Disability and rehabilitation 2016; (38(11)):1063-74 doi:10.3109/09638288.2015.1092175.

    PMID: 26497567
  26. 26

    Treating pain related to Ehlers-Danlos syndrome with medical cannabis.

    Dar S

    BMJ case reports 2021; (14(7)) doi:10.1136/bcr-2021-242568.

    PMID: 34301703
  27. 27

    A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.

    Chohan K, Mittal N, McGillis L, et al.

    Chronic respiratory disease 2021; (18()):14799731211025313 doi:10.1177/14799731211025313.

    PMID: 34291699
  28. 28

    Evidence for central sensitization as classified by the central sensitization inventory in patients with pain and hypermobility.

    Desai MJ, Brestle M, Jonely H

    Pain practice : the official journal of World Institute of Pain 2025; (25(1)):e13411 doi:10.1111/papr.13411.

    PMID: 39192465
  29. 29

    Glycine substitution mutation of COL5A1 in classic Ehlers-Danlos syndrome: a case report and literature review.

    Gong Z, Wang H, Lin Z

    Clinical and experimental dermatology 2021; (46(5)):987-989 doi:10.1111/ced.14568.

    PMID: 33656776
  30. 30

    Obstetrics and gynecology in Ehlers-Danlos syndrome: A brief review and update.

    Blagowidow N

    American journal of medical genetics. Part C, Seminars in medical genetics 2021; (187(4)):593-598 doi:10.1002/ajmg.c.31945.

    PMID: 34773390
  31. 31

    Classical Ehlers-Danlos syndrome with cranio-cervical instability in an infant due to a novel COL5A1 gene mutation.

    Thomas Paulraj H, Balasubramanian M, Chinnasamy V, Selvaraj R

    BMJ case reports 2024; (17(12)) doi:10.1136/bcr-2024-262894.

    PMID: 39950632
  32. 32

    Arterial complications in classical Ehlers-Danlos syndrome: a case series.

    Angwin C, Brady AF, Pope FM, et al.

    Journal of medical genetics 2020; (57(11)):769-776 doi:10.1136/jmedgenet-2019-106689.

    PMID: 32467296
  33. 33

    A family with Classical Ehlers-Danlos Syndrome (cEDS), mild bone fragility and without vascular complications, caused by the p.Arg312Cys mutation in COL1A1.

    Duong J, Rideout A, MacKay S, et al.

    European journal of medical genetics 2020; (63(2)):103730 doi:10.1016/j.ejmg.2019.103730.

    PMID: 31323331
  34. 34

    Aortic Dissection in a Patient with Novel Frameshift COL5A1 Variant of Classical Ehlers-Danlos Syndrome.

    Caley L, Campar A, Mendonça T, Farinha F

    European journal of case reports in internal medicine 2023; (10(2)):003698.

    PMID: 36970158
  35. 35

    Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers-Danlos syndrome.

    Shalhub S, Neptune E, Sanchez DE, et al.

    American journal of medical genetics. Part A 2019; (179(5)):797-802 doi:10.1002/ajmg.a.61094.

    PMID: 30793832
  36. 36

    Iatrogenic distal aortic rupture in a patient with vascular Ehlers-Danlos syndrome.

    Zagzoog MM, Crawford SA, Le Houérou T, et al.

    Journal of vascular surgery cases and innovative techniques 2023; (9(2)):101156 doi:10.1016/j.jvscit.2023.101156.

    PMID: 37125345
  37. 37

    Intramuscular hemorrhage during rehabilitation in a post-stroke patient with vascular Ehlers-Danlos syndrome: a case report and review of spasticity-related muscle injury.

    Izumi R, Hayashi K, Sato M, et al.

    Frontiers in rehabilitation sciences 2025; (6()):1638656 doi:10.3389/fresc.2025.1638656.

    PMID: 41020269
  38. 38

    Surgical management of vascular Ehlers-Danlos syndrome and its challenges: a case report.

    da Rocha de Sousa F, Colucci N, Dupuis A, et al.

    Swiss medical weekly 2020; (150()):w20379.

    PMID: 33277910
  39. 39

    Successful multidisciplinary management of vascular Ehlers-Danlos syndrome.

    Kanaka S, Yamada T, Matsuda A, et al.

    Clinical journal of gastroenterology 2022; (15(1)):146-150 doi:10.1007/s12328-021-01562-9.

    PMID: 34845584
  40. 40

    A case of sigmoid colon perforation due to segmental absence of intestinal musculature (SAIM) accompanied by vascular Ehlers-Danlos syndrome: a case report.

    Funaki K, Akagi T, Shiroshita H, et al.

    Surgical case reports 2023; (9(1)):138 doi:10.1186/s40792-023-01721-9.

    PMID: 37530898
  41. 41

    [Up-to-date classification and multidisciplinary symptoms of Ehlers-Danlos syndromes].

    Ralovich FV, Kiss N, Horváth K, et al.

    Orvosi hetilap 2019; (160(16)):603-612 doi:10.1556/650.2019.31351.

    PMID: 30983397
  42. 42

    Establishing an Ehlers-Danlos Syndrome Clinic: Lessons Learned.

    Knight DRT, Confiado SM, Bruno KA, et al.

    SN comprehensive clinical medicine 2022; (4(1)):138 doi:10.1007/s42399-022-01218-w.

    PMID: 35811641
  43. 43

    No Increase in Acute or Late Radiation Toxicities in Patients With Ehlers-Danlos Syndrome Receiving Adjuvant Breast Radiation Therapy: A Report of Four Cases With Extended Follow-Up.

    Hsieh MT, Amalaseelan J, Mohd Tahir AR, et al.

    Cureus 2023; (15(12)):e50346 doi:10.7759/cureus.50346.

    PMID: 38205452
  44. 44

    Integrative medicine for hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS): a feasibility study.

    Guedry SE, Langley BO, Schaefer K, Hanes DA

    Disability and rehabilitation 2024; (46(24)):5854-5867 doi:10.1080/09638288.2024.2314713.

    PMID: 38353245
  45. 45

    Understanding the issues of hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome in primary care: a qualitative integrative review.

    Jones E, Carrieri D

    Disability and rehabilitation 2025; 1-16 doi:10.1080/09638288.2025.2517246.

    PMID: 40534133
  46. 46

    Comorbidity, misdiagnoses, and the diagnostic odyssey in patients with hypermobile Ehlers-Danlos syndrome.

    Halverson CME, Cao S, Perkins SM, Francomano CA

    Genetics in medicine open 2023; (1(1)):100812 doi:10.1016/j.gimo.2023.100812.

    PMID: 39669244
  47. 47

    Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.

    Estrella E, Frazier PA

    Disability and rehabilitation 2024; (46(4)):731-740 doi:10.1080/09638288.2023.2176554.

    PMID: 36772820

This page provides educational information about pain management strategies for Ehlers-Danlos Syndrome. It does not replace professional medical advice. Always consult your healthcare team before starting new physical therapies or medications.

Stay up to date

Get notified when new research about Ehlers Danlos Syndrome (EDS) is published.

No spam. Unsubscribe anytime.